These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29925342)

  • 1. Ursodeoxycholic acid versus phenobarbital for cholestasis in the Neonatal Intensive Care Unit.
    Lewis T; Kuye S; Sherman A
    BMC Pediatr; 2018 Jun; 18(1):197. PubMed ID: 29925342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of conjugated bilirubin trajectory in neonates following parenteral nutrition cessation.
    Mangalat N; Bell C; Graves A; Imseis EM
    BMC Pediatr; 2014 Dec; 14():298. PubMed ID: 25492029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholestasis affects enteral tolerance and prospective weight gain in the NICU.
    Niccum M; Khan MN; Middleton JP; Vergales BD; Syed S
    Clin Nutr ESPEN; 2019 Apr; 30():119-125. PubMed ID: 30904211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of obstructive jaundice in erythroblastosis fetalis with ursodeoxycholic acid (UDCA): a case report.
    Perez EM; Cooper TR; Moise AA; Ferry GD; Weisman LE
    J Perinatol; 1998; 18(4):317-9. PubMed ID: 9730206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of routine laboratory screening in the neonatal intensive care unit.
    Kazmi SH; Caprio M; Boolchandani H; Mally P; Bailey S; Desai P
    J Neonatal Perinatal Med; 2020; 13(2):247-251. PubMed ID: 31796688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholestasis in neonatal intensive care unit: incidence, aetiology and management.
    Tufano M; Nicastro E; Giliberti P; Vegnente A; Raimondi F; Iorio R
    Acta Paediatr; 2009 Nov; 98(11):1756-61. PubMed ID: 19664101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursodeoxycholic acid therapy for intractable total parenteral nutrition-associated cholestasis in surgical very low birth weight infants.
    Al-Hathlol K; Al-Madani A; Al-Saif S; Abulaimoun B; Al-Tawil K; El-Demerdash A
    Singapore Med J; 2006 Feb; 47(2):147-51. PubMed ID: 16435058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parenteral nutrition-associated cholestasis in preterm neonates: evaluation of ursodeoxycholic acid treatment.
    Levine A; Maayan A; Shamir R; Dinari G; Sulkes J; Sirotta L
    J Pediatr Endocrinol Metab; 1999; 12(4):549-53. PubMed ID: 10417972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ursodeoxycholic acid in the treatment of cholestasis and hyperbilirubinemia in pediatric intensive care unit patients.
    George R; Stevens A; Berkenbosch JW; Turpin J; Tobias J
    South Med J; 2002 Nov; 95(11):1276-9. PubMed ID: 12539993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High rates of mortality and morbidity occur in infants with parenteral nutrition-associated cholestasis.
    Willis TC; Carter BA; Rogers SP; Hawthorne KM; Hicks PD; Abrams SA
    JPEN J Parenter Enteral Nutr; 2010; 34(1):32-7. PubMed ID: 19587385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed postnatal presentation of biliary atresia in 2 premature neonates.
    Mourier O; Franchi-Abella S; Ackermann O; Branchereau S; Gonzales E; Bernard O; Jacquemin E
    J Pediatr Gastroenterol Nutr; 2011 Apr; 52(4):489-91. PubMed ID: 21407106
    [No Abstract]   [Full Text] [Related]  

  • 12. Management options for cholestatic liver disease in children.
    Catzola A; Vajro P
    Expert Rev Gastroenterol Hepatol; 2017 Nov; 11(11):1019-1030. PubMed ID: 28745070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year experience of obstetric cholestasis: outcome and management.
    Deveer R; Engin-Ustun Y; Celen S; Eryilmaz OG; Tonguç E; Mollamahmutoğlu L; Oksuzoglu A; Danisman N
    Clin Exp Obstet Gynecol; 2011; 38(3):256-9. PubMed ID: 21995159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ursodiol in patients with parenteral nutrition-associated cholestasis.
    San Luis VA; Btaiche IF
    Ann Pharmacother; 2007 Nov; 41(11):1867-72. PubMed ID: 17911205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of cholestatic pruritus in children.
    Cies JJ; Giamalis JN
    Am J Health Syst Pharm; 2007 Jun; 64(11):1157-62. PubMed ID: 17519457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ursodeoxycholic acid treatment in preterm infants: a pilot study for the prevention of cholestasis associated with total parenteral nutrition.
    Arslanoglu S; Moro GE; Tauschel HD; Boehm G
    J Pediatr Gastroenterol Nutr; 2008 Feb; 46(2):228-31. PubMed ID: 18223390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of severe cholestasis in neonatal Dubin-Johnson syndrome with ursodeoxycholic acid.
    Regev RH; Stolar O; Raz A; Dolfin T
    J Perinat Med; 2002; 30(2):185-7. PubMed ID: 12012642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The influence of combined therapy with orotic acid and phenobarbital on the level of serum bilirubin in premature infants].
    Hinkel GK; Schwarze R; Kintzel HW
    Schweiz Med Wochenschr; 1972 Mar; 102(10):331-5. PubMed ID: 5034967
    [No Abstract]   [Full Text] [Related]  

  • 19. [Correction of metabolic disturbances in patients with cholestasis].
    Rodonezhskaia EV; Kharchenko NV
    Lik Sprava; 2001; (3):148-9. PubMed ID: 11560006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ursodeoxycholic acid therapy in children with cholestatic liver disease.
    Dinler G; Koçak N; Yüce A; Gürakan F; Ozen H
    Turk J Pediatr; 1999; 41(1):91-8. PubMed ID: 10770681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.